Tulsa Pharmaceutical Firm Acquired By International Company

A Tulsa business has announced it has been acquired by Fagron, a global leader in pharmaceutical compounding.  

Freedom Pharmaceuticals, a privately held company, specializes in the custom wholesale distribution of fine compounding chemicals.  

"I am looking forward to combining forces with the Fagron Group. Fagron's global and rapidly expanding network offers great potential to roll out successful and unique products and concepts internationally," Jacob Jackson, President of Freedom Pharmaceuticals, said. "Our clients will benefit from an excellent range of more than 1,500 high quality products and services, and our employees will enjoy opportunities for further development in an international environment." 

Jackson will continue to serve as President and CEO of Freedom Pharmaceuticals and will assume the position of President of Fagron North America in January 2014.

Read Fagron news release.